par Vonèche, Véronique;Portetelle, Daniel ;Kettmann, Richard ;Willems, Lucas ;Limbach, K;Paoletti, E;Ruysschaert, Jean Marie ;Burny, Arsène ;Brasseur, Robert
Référence Proceedings of the National Academy of Sciences of the United States of America, 89, 9, page (3810-3814)
Publication Publié, 1992-05
Référence Proceedings of the National Academy of Sciences of the United States of America, 89, 9, page (3810-3814)
Publication Publié, 1992-05
Article révisé par les pairs
Résumé : | Modified bovine leukemia virus (BLV) glycoproteins were expressed by using vaccinia virus recombinants, and their fusogenic capacities were examined by a syncytia-formation assay. This analysis indicates that (i) both BLV envelope glycoproteins gp51 and gp30 are necessary for cell fusion; (ii) insertion of the N-terminal segment of gp30 (fusion peptide) into the lipid bilayer in an oblique orientation, as predicted by computer conformational analysis, results in fusogenic capacities higher than insertion in a perpendicular or parallel orientation; and (iii) replacement of the BLV fusion peptide with its simian immunodeficiency virus counterpart does not modify the fusogenic capacity of the BLV glycoprotein. |